This inventor holds 3 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, University of Alberta. Active years: 2001-2008.
Company Filing History:
3 out of 2,198 
2 out of 454 
Years Active: 2001-2008
Title: Innovations by John Patrick Griffin
Introduction
John Patrick Griffin is a notable inventor based in Worthing, GB. He has made significant contributions to the field of biotechnology, particularly in the development of novel bacterial genes and processes. With a total of 3 patents to his name, Griffin's work has had a substantial impact on the manufacture of important pharmaceutical compounds.
Latest Patents
Griffin's latest patents include groundbreaking research on novel bacterial genes, microorganisms, and processes aimed at improving the manufacture of 5R clavams, such as clavulanic acid. His work involves isolated DNA that comprises one or more genes specific for 5S clavam biosynthesis, as well as vectors that include such DNA and streptomyces hosts capable of enhanced clavulanic acid production.
Career Highlights
Throughout his career, Griffin has worked with prominent organizations, including SmithKline Beecham Corporation and the University of Alberta. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.
Collaborations
Some of Griffin's notable coworkers include Cecilia Anders and Barry Barton. Their collaborative efforts have furthered the research and development of innovative solutions in the industry.
Conclusion
John Patrick Griffin's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the manufacture of essential pharmaceutical compounds, showcasing the importance of innovation in science and technology.